Chronic kidney disease management and emerging regenerative treatments

Chronic kidney disease (CKD) is a progressive condition characterized by a gradual decline in kidney function due to inflammation, oxidative stress, and fibrosis. Because damage often occurs silently, symptoms such as fatigue, swelling, and changes in urination patterns may only appear once the disease is advanced.

Management of early-stage CKD focuses on slowing progression through blood pressure control and dietary adjustments. Medications such as ACE inhibitors, angiotensin receptor blockers (ARBs), and SGLT2 inhibitors have shown efficacy in protecting kidney function. Dietary management includes reducing sodium intake and tailoring protein, potassium, and phosphorus consumption based on individual medical needs.

Emerging research is exploring regenerative medicine, specifically stem cell treatments, to target kidney injury at the cellular level. These approaches aim to provide immunomodulation and boost natural repair mechanisms, offering potential new avenues for treating the disease beyond current symptom management.